Alpha Teknova (TKNO) to Release Quarterly Earnings on Wednesday

Alpha Teknova (NASDAQ:TKNO) is expected to be issuing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Alpha Teknova to post earnings of ($0.0833) per share and revenue of $10.9610 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 6:00 PM ET.

Alpha Teknova (NASDAQ:TKNO) last announced its earnings results on Wednesday, May 6th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.01. Alpha Teknova had a negative return on equity of 24.32% and a negative net margin of 41.07%.The firm had revenue of $11.08 million for the quarter, compared to the consensus estimate of $10.23 million.

Alpha Teknova Stock Performance

NASDAQ:TKNO opened at $5.00 on Monday. Alpha Teknova has a 1 year low of $1.91 and a 1 year high of $6.68. The stock has a market cap of $268.05 million, a price-to-earnings ratio of -15.62 and a beta of 0.64. The business has a fifty day moving average of $5.08 and a 200-day moving average of $3.68. The company has a debt-to-equity ratio of 0.20, a quick ratio of 3.60 and a current ratio of 4.59.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Susquehanna International Group LLP boosted its stake in shares of Alpha Teknova by 25.0% during the 3rd quarter. Susquehanna International Group LLP now owns 16,206 shares of the company’s stock worth $100,000 after acquiring an additional 3,246 shares in the last quarter. Larson Financial Group LLC lifted its holdings in shares of Alpha Teknova by 58.5% during the third quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after purchasing an additional 3,464 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Alpha Teknova by 123.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock valued at $40,000 after purchasing an additional 4,504 shares during the period. Bridgeway Capital Management LLC increased its stake in Alpha Teknova by 7.9% in the 3rd quarter. Bridgeway Capital Management LLC now owns 80,900 shares of the company’s stock worth $501,000 after purchasing an additional 5,900 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Alpha Teknova in the 2nd quarter worth about $29,000. Institutional investors own 13.81% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alpha Teknova in a report on Friday, July 17th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Reduce”.

Alpha Teknova Company Profile

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.